Clinical trial

Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence

NCT01874951

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-06-01

PhasePHASE2

Study timeline

Study start (unknown)2013-06-01Date precision: month

Registry last updated2017-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Depression, Unipolarcandidate · MONDO: major depressive disorder

Recurrenceunresolved

Relapseunresolved

Interventions

NaltrexoneDRUG · verified · RxNorm: naltrexone

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Boston Clinical Trialscollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01874951 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.